Ledger. Australian venture funding, tracked

Person

David Hoey

Coverage

Stories naming David Hoey. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

2 deals

Vaccination biotech Vaxxas raises $49 million Series D, cuts C-suite amid broader layoffs

Australian biotech Vaxxas secured a Series D plus a debt facility while overhauling leadership: a new chair, founding CEO shifting to an advisory role, and CFO made redundant amid job cuts.

Also Business News Australia·SmartCompany·Cut Through Venture·Startup Daily·Startup Daily·SmartCompany·Startup Daily

Something wrong? Tell us